Chang Chun, China Clinical Trials

A listing of Chang Chun, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
Assess the Efficacy and Safety of SHR0302 Ointment in Adult Patients With Vitiligo

The purpose of this study is to assess the efficacy and safety of SHR0302 ointment in adult patients with Vitiligo.

The First Hospital of Jillin University
 (3.5 away) Contact site
  • 0 views
  • 17 Apr, 2021
  • +15 other locations
Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy

To compare and evaluate the efficacy and safety of Liporaxel solution (oral paclitaxel) and Taxol (IV paclitaxel) on recurrent or metastatic breast cancer.

Harbin Medical University Cancer Hospital
 (149.0 away) Contact site
  • 10 views
  • 23 Jan, 2021
  • +35 other locations
First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System Metastases

Primary Hypothesis The first-line treatment with single agent AZD3759 results in superior Progression Free Survival (PFS) compared to Standard of Care (SoC) Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI), in patients with advanced Non-Small Cell Lung Cancer (NSCLC) with Central Nervous System (CNS) metastasis Secondary Hypothesis The safety profile …

gefitinib
lung carcinoma
cancer
metastasis
epidermal growth factor
China site 0116
 (3.5 away) Contact site
  • 53 views
  • 25 Jan, 2021
  • +58 other locations
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC)

Study consists of an open-label, safety run-in part and a randomized, double-blind, placebo-controlled Phase 2/3 part. In the Phase 2/3 part, the study will evaluate whether bintrafusp alfa in combination with the current standard of care (SoC) (gemcitabine plus cisplatin) improves overall survival (OS) in chemotherapy and immunotherapy-nave participants with …

gemcitabine/cisplatin
cancer
measurable disease
renal function
cisplatin/gemcitabine
The First Hospital of Jilin University
 (3.5 away) Contact site
  • 173 views
  • 05 May, 2021
  • +125 other locations
Combination Margetuximab INCMGA00012 MGD013 and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer (MAHOGANY)

This is a Phase 2/3, randomized, open-label study for the treatment of patients with HER2-positive Gastric cancer (GC) or Gastroesophageal Junction (GEJ) cancer to determine the efficacy of margetuximab combined with INCMGA00012 (also known as MGA012) (Cohort A) and margetuximab combined with INCMGA00012 or MGD013 and chemotherapy compared to trastuzumab …

capecitabine
HER2
erbb2
adenocarcinoma
oxaliplatin
Jilin Cancer Hospital (Second People's Hospital Of Jilin Province)
 (5.2 away) Contact site
  • 14 views
  • 09 May, 2021
  • +64 other locations
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

remission
The First Hosp of Jilin Univ /ID# 212278
 (3.5 away) Contact site
  • 604 views
  • 13 Jun, 2021
  • +772 other locations
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis (UC).

medical therapy
China-Japan Union Hospital of Jilin University
 (3.2 away) Contact site
  • 226 views
  • 13 Jun, 2021
  • +516 other locations
TPM Regimen (Thalidomide Prednisone and Methotrexate) in LGLL

Large granular lymphocytic leukemia (LGLL) is a lymphoproliferative disease, with LGL infiltration in peripheral blood and bone marrow, hepatosplenomegaly, and cytopenia. Both T-LGLL and CLPD-NK are indolent disease and share similar biology and clinical course, and treated under the same strategy. So the investigators put them together as LGLL. The …

lymphoid leukemia
The First Affiliated Hospital of Jilin University
 (5.2 away) Contact site
  • 0 views
  • 24 Jan, 2021
  • +8 other locations